Duke University

FDA study finds little harm in 'distracting visuals'

FDA study finds little harm in 'distracting visuals'

By

An FDA study on the power of background visuals found no evidence that consumer understanding of risk info is affected by the "emotional (affective) tone of images."

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.